Disulphide bonds in secreted proteins are considered to be inert because of
the oxidizing nature of the extracellular milieu. An exception to this rul
e is a reductase secreted by tumour cells that reduces disulphide bonds in
the serine proteinase plasmin(1,2). Reduction of plasmin initiates proteoly
tic cleavage in the kringle 5 domain and release of the tumour blood vessel
inhibitor angiostatin(3). New blood vessel formation or angiogenesis is cr
itical for tumour expansion and metastasis(4,5). Here we show that the plas
min reductase isolated from conditioned medium of fibrosarcoma cells is the
glycolytic enzyme phosphoglycerate kinase(6). Recombinant phosphoglycerate
kinase had the same specific activity as the fibrosarcoma-derived protein.
Plasma of mice bearing fibrosarcoma tumours contained several-fold more ph
osphoglycerate kinase, as compared with mice without tumours. Administratio
n of phosphoglycerate kinase to tumour-bearing mice caused an increase in p
lasma levels of angiostatin, and a decrease in tumour vascularity and rate
of tumour growth. Our findings indicate that phosphoglycerate kinase not on
ly functions in glycolysis but is secreted by tumour cells and participates
in the angiogenic process as a disulphide reductase.